ATP announced the launch of Marengo Therapeutics with $80 million in launch financing.
Marengo Therapeutics is pioneering first-in-class therapeutics that activate the right immune response to promote lifelong protection against cancer.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
